Try our Advanced Search for more refined results

USPTO Can't Be Blamed For Patent On 'Fraud' Stem Cells

By Ryan Davis ( February 19, 2014, 8:49 PM EST) -- The U.S. Patent and Trademark Office's decision to issue a human stem cell patent to a scientist found years ago to have fabricated his work may seem like sloppy work by the agency, but attorneys say the office doesn't have the ability to test the bona fides of an invention, nor does it need to in a system that renders fraudulent patents unenforceable....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Government Agencies

Patents

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!